Which statin is most efficient for the treatment of hypercholesterolemia? a cost-effectiveness analysis

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Scott M. Grundy · JAMA · 1993 · 27.9K citations

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health

Archives of Internal Medicine · 1991 · 1.1K citations

Medicine, Cardiology, Dermatology +13

National cholesterol education program: Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II)

Scott M. Grundy · Circulation · 1994 · 477 citations

Medicine, Health Education, Preventive Medicine +15

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole*

Pertti J. Neuvonen, Teemu Kantola, Kari T. Kivistö · Clinical Pharmacology & Therapeutics · 1998 · 403 citations

Pharmacy, Pharmacokinetics, Pharmacology +11

High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators.

R. Masiá, Jaume Marrugat, Joan Sala et al. · Journal of Epidemiology & Community Health · 1998 · 297 citations · Full text

Medicine, Cardiology, Population Health Sciences +16